Researchers estimate that about 20 percent of breast cancers are triple-negative tumors, but many people may not understand what this means. Triple-negative breast cancer tumors are ER-negative, PR-negative and HER2-negative, meaning they don't respond to any of the targeted therapies usually employed in the treatment of breast cancer. These cancers do have a good response to chemotherapy, and more research is underway.
Watch Dr. Susan Love of the namesake research foundation explain this disease in an approachable way using bright, fun animation in this video! To find out more about current advances in triple-negative breast cancer research, click here.Whizzco